Treatment of Duodenal Ulcer with Sucralfate

References

• Lam S K. Why do ulcers heal with sucralfate?. Scan J Gastroenterol 1990; 25(suppl 173)6–16
   Google Scholar
• Brandstaetter G. Comparison of two sucralfate dosages (2 g twice a day versus 1 g four times a day) in duodenal ulcer healing. Am J Med 1985; 79(suppl 2C)36–38
   PubMed Web of Science ®Google Scholar
• Marks I N, Wright J P, Gilinsky N H, et al. A comparison of sucralfate dosage schedule in duodenal ulcer healing. Two grams twice a day versus one gram four times a day. J Clin Gastroenterol 1986; 8: 419–423
   PubMed Web of Science ®Google Scholar
• Coste T, Rautureau J, Beaugrand M, et al. Comparison of two sucralfate dosages presented in tablet form in duodenal ulcer healing. Am J Med 1987; 83(suppl 3B)86–90
   PubMed Web of Science ®Google Scholar
• Shubert T, Multicenter Study Group. Twice daily sucralfate dosing heals acute duodenal ulcer. Am J Med 1989; 86(suppl 6A)108–112
   Web of Science ®Google Scholar
• Nakazawa S, Nagashima R, Samloff I M. Selective binding of sucralfate to gastric ulcer in men. Dig Dis Sci 1981; 26: 297–300
   PubMed Web of Science ®Google Scholar
• Nagashima R. Mechanisms of action of sucralfate. J Clin Gastroenterol 1981; 3(suppl 2)117–127
   PubMed Web of Science ®Google Scholar
• Tarnawski A, Hollander D, Gergely H. The mechanism of protective, therapeutic and prophylactic actions of sucralfate. Scand J Gastroenterol 1987; 22(suppl 140)7–13
   Google Scholar
• Crampton J R, Gibbons L C, Rees W DW. Effect of sucralfate on gastroduodenal bicarbonate secretion and mucosal prostaglandin E2 metabolism. Scand J Gastroenterol 1987; 22(suppl 140)15–18
   Google Scholar
• Konturek E J, Kwiecien N, Obtulowicz W, Olesky J. Gastroprotection by sucralfate against acetylsalicylic acid in humans. Role of endogenous prostaglandins. Scand J Gastroenterol 1987; 22(suppl 140)19–22
   Google Scholar
• Quadros E, Ramsamvoj E, Wilson D E. Role of mucus and prostaglandins in the gastric mucosal protective actions of sucralfate against ethanol-induced injury in the rat. Am J Med 1987; 83(suppl 3B)19–23
   PubMed Web of Science ®Google Scholar
• Coleman J C, Laez J P, Browne R K, Dress D T. Effects of sucralfate or mild irritants on experimental gastritis and prostaglandin production. Am J Med 1987; 83(suppl 3B)24–30
   PubMed Web of Science ®Google Scholar
• Morris G P, Keenan C M, Wallace K L, Mac-Naughton W K, Wallace J L, Williamson T E. Protection of rat gastric mucosa by sucralfate: effects of luminal stasis and of inhibition of prostaglandin synthesis. Am J Med 1989; 86(suppl 6A)10–16
   PubMed Web of Science ®Google Scholar
• Chen B W, Hui W M, Lam S K, Cho C H, Ng M MT, Luk C T. Effect of sucralfate on gastric mucosal blood flow in rats. Gut 1989; 30: 1544–1551
   PubMed Web of Science ®Google Scholar
• Konturek S J, Brzozowski T, Bielanski W, Warzecha Z, Drozdowics D. Epidermal growth factor in the gastroprotective and ulcer healing actions of sucralfate in rats. Am J Med 1989; 86(suppl 6A)32–37
   PubMed Web of Science ®Google Scholar
• Brand D L, Ronfail W M, Thomson A BR, Tapper E J. Ulisoprostol, synthetic PGE, analogue, in the treatment of duodenal ulcers: a multicenter double-blind study. Dig Dis Sci 1985; 30: 147S–158S
   PubMed Web of Science ®Google Scholar
• Isenberg J I, Hogan D L, Thomas F J. Duodenal mucosal bicarbonate secretion in humans: a brief review. Scand J Gastroenterol 1986; 21(suppl 125)106–109
   Google Scholar
• Kollberg B, Slezak P. The effect of prostaglandin E2 on duodenal ulcer healing. Prostaglandins 1982; 24: 527–536
   PubMed Web of Science ®Google Scholar
• Marks I N, Wright J P, Denyer M, Garish J AM, Lucke W. Comparison of sucralfate with cimetidine in the short-term treatment of chronic peptic ulcers. S Afr Med J 1980; 57: 567–573
   PubMed Web of Science ®Google Scholar
• Branstaetter G. Comparison of two sucralfate dosages (2 g twice a day versus 1 g four times a day) in duodenal ulcer healing. Am J Med 1985; 79(suppl 2C)36–38
   Web of Science ®Google Scholar
• Lam K T, Lai S T, Kan Y S, Chan A YT. Sucralfate compared with ranitidine in the short-term healing of duodenal ulcers. J Int Med Res 1985; 13: 338–341
   PubMed Web of Science ®Google Scholar
• Marks I N, Wright J P, Glinsky N H, et al. A comparison of sucralfate dosage schedule in duodenal ulcer healing. Two grams twice a day vs one gram four times a day. J Clin Gastroenterol 1986; 8: 419–423
   PubMed Web of Science ®Google Scholar
• Lam S K, Hui W M, Lau W Y, et al. Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology 1987; 92: 1193–1201
   PubMed Web of Science ®Google Scholar
• Coste T, Rautureau J, Beaugrand M, et al. Comparison of two sucralfate dosages presented in tablet form in duodenal ulcer healing. Am J Med 1987; 83(suppl 3B)83–90
   Web of Science ®Google Scholar
• Harley H, Alp M H. Treatment of chronic duodenal ulceration. Effectiveness of colloidal bismuth sub-citrate tablets compared with cimetidine. Med J Aust 1983; 2: 627–628
   PubMed Web of Science ®Google Scholar
• Shreeve D R, Klass H J, Jones P E. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers. Digestion 1983; 28: 96–101
   PubMed Web of Science ®Google Scholar
• Hamilton I, O'Connor H J, Wood N C, Bradbury I, Axon A TR. Healing and recurrence of duodenal ulcer after treatment of dicitrato bismuthate (TCB) tablets or cimetidine. Gut 1986; 27: 105–110
   Web of Science ®Google Scholar
• Martin D F, Hollanders D, May S J, et al. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1981; 1: 7–10
   PubMed Web of Science ®Google Scholar
• Kang J Y, Piper D W. Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer comparison of initial healing and recurrence after healing. Digestion 1982; 23: 73–79
   PubMed Web of Science ®Google Scholar
• Lee F L, Samloff I M, Hardman M. Comparison of tripotassium dicitrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet 1985; 1: 1299–1302
   PubMed Web of Science ®Google Scholar
• Coghlan J G, Gilligan D, Humphries H, et al. Campylobacter pylori and recurrence of duodenal ulcers—12 months follow-up study. Lancet 1987; 2: 1107–1111
   Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–1441
   PubMed Web of Science ®Google Scholar
• Gibinski K, Nowak A, Malicz K, et al. Dicytrynianobizmutan trojpotasowy w leczeniu wrzodu traawiennego i zapobieganiu nawrotowi wrzodu. Pol Tyg Lek 1984; 39: 1547–1550
   PubMedGoogle Scholar
• Lambert J R, Borromeo M, Korman M G, Hansky J, Eaves E R. Effect of colloidal bismuth (De-Nol) on healing and relapse of duodenal ulcers—role of Campylobacter pyloridis [Abstract]. Gastroenterology 1987; 92: 1489
   Web of Science ®Google Scholar
• Smith A C, Price A B, Borriello P, Levi A J. A comparison of ranitidine and tripotassium dicitrato-bismuth (T.D.B.) in relapse rates of duodenal ulcer. The role of Campylobacter pylori (C.P.) [Abstract]. Gastroenterology 1988; 94: A431
   Web of Science ®Google Scholar
• Marks I N, Wright J P, Lucke W, et al. Relapse rates following initial ulcer healing with sucralfate and cimetidine. Scand J Gastroenterol 1982; 17: 429–432
   PubMed Web of Science ®Google Scholar
• Hentschel E, Schuelze K, Dufek W. Recurrence of duodenal ulcers following treatment with sucralfate or cimetidine [Abstract]. Wien Klin Wochenschr 1984; 96: 153
   PubMed Web of Science ®Google Scholar
• Hallerback B, Solhaug J H, Carling L, et al. Recurrent ulcer after treatment with cimetidine or sucralfate. Scand J Gastroenterol 1987; 22: 791–797
   PubMed Web of Science ®Google Scholar
• Koelz H R, Falter F. Sucralfate and ranitidine in the treatment of acute duodenal ulcer: healing and relapse. Am J Med 1989; 86(suppl 6A)98–103
   PubMed Web of Science ®Google Scholar
• Domschke S. Longer relapse free period after acute treatment with sucralfate than after H2-blocker in peptic ulcer patients [Abstract]. 6th International Sucralfate Symposium Abstracts. ADIS Press, 1990; 28
   Google Scholar
• Tovey F I, Husband E M, Yiu Y C, et al. Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year's maintenance with cimetidine or sucralfate: a light and electron microscopy study. Gut 1989; 30: 586–693
   PubMed Web of Science ®Google Scholar
• Lam S K. Implications of sucralfate-induced ulcer healing and relapse. Am J Med 1989; 86(suppl 6A)122–126
   PubMed Web of Science ®Google Scholar
• Hui W M, Lam S K, Ho J, et al. Effect of sucralfate and cimetidine on duodenal ulcer associated antral gastritis and Campylobacter pylori. Am J Med 1989; 86(suppl 6A)60–65
   PubMed Web of Science ®Google Scholar
• Slomiany B L, Piotrowski J, Samanta A, VanHorn K, Murty V LN, Slomiany A. Campylobacter pylori colonization factor shows specificity for lactosylcer-amide sulfate and GM3 ganglioside. Biochem Int 1989; 19: 929–936
   PubMedGoogle Scholar
• Moshal M G, Gregory M A, Pillay C, Spitaels J M. Does the duodenal cell evcr return to normal? A comparison between treatmeiit with cimetidine and De-Nol. Scand J Gastroenterol 1979; 14(suppl 54)48–51
   Google Scholar
• Libeskind M. Maintenance treatment of patients with healed peptic ulcer with sucralfate, placebo and cimetidine. Scand J Gastroenterol 1983; 18(suppl 83)69–70
   Google Scholar
• Moshal M G, Spitaels J-M, Manion G L. Double-blind placebo-controlled evaluation of onc year therzpy with sucralfate in healed duodenal ulcer. Scand J Gastroenterol 1983; 18(suppl 83)57–59
   PubMed Web of Science ®Google Scholar
• Classen M, Bethge H, Brunner G, et al. Effect of sucralfate on peptic ulcer recurrence: a controlled double-blind multicenter study. Scand J Gastro-enterol 1983; 18(suppl 83)61–68
   PubMed Web of Science ®Google Scholar
• Marks I N, Girdwood A H. Recurrence of duodenal ulceration in patients on maintenance sucralfate: a 12-month follow-up study. S Afr Med J 1985; 67: 626–628
   PubMed Web of Science ®Google Scholar
• Masoero G, Rocchia F, Rossanino A, Marchetto M, Benitti V, De la Pierre M. Comparison of ranitidine and sucralfate in the long-term treatment of duodenal ulcer. J Clin Gastroenterol 1986; 8: 624–627
   PubMed Web of Science ®Google Scholar
• Bolin T TD, Davis A E, Duncombe V M, Billington B. Role of maintenance sucralfate in prevention of duodenal ulcer recurrence. Am J Med 1987; 83(suppl 38)91–94
   PubMed Web of Science ®Google Scholar
• Rodrigo M, Berenguer J, Hinojosa J, Balanzo J, Segu J. Sucralfate and timetidine as maintenance treatment in the prevention of duodenal ulcer recurrence. Am J Med 1987; 83(suppl 3B)99–104
   PubMed Web of Science ®Google Scholar
• Paakkonen M, Aukee S, Janatuinen E, et al. Sucralfate as maintenance treatment for the prevention of duodenal ulcer recurrence. Am J Med 1989; 86(suppl 6A)133–135
   PubMed Web of Science ®Google Scholar
• Bynum T E, Koch G G. Sucralfate tablets 1 g twice a day for the prevention of duodenal ulcer recurrence. Am J Med 1989; 86(suppl 6A)127–132
   PubMed Web of Science ®Google Scholar
• Marks I N, Girdwood A H, Newton K A, O'Keefe S J, Marotta F, Lucke W. A maintenance regimen of sucralfate 2 g at night for reduced relapse rate in duodenal ulcer disease: a one-year follow-up study. Am J Med 1989; 86(suppl 6A)136–140
   PubMed Web of Science ®Google Scholar
• Hui W M, Lam S K, Ng M MT, Lai C L, Lok A SF. Long-term maintenance therapy for duodenal ulcer: a comparison of 8 forms of treatment [Abstract]. Gastroenterology 1989; 96: A221
   Google Scholar